32
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mutations in RAB39B in individuals with intellectual disability, autism spectrum disorder, and macrocephaly

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Autism spectrum disorder (ASD), a developmental disorder of early childhood onset, affects males four times more frequently than females, suggesting a role for the sex chromosomes. In this study, we describe a family with ASD in which a predicted pathogenic nonsense mutation in the X-chromosome gene RAB39B segregates with ASD phenotype.

          Methods

          Clinical phenotyping, microarray, and whole genome sequencing (WGS) were performed on the five members of this family. Maternal and female sibling X inactivation ratio was calculated, and phase was investigated. Mutant-induced pluripotent stem cells engineered for an exon 2 nonsense mutation were generated and differentiated into cortical neurons for expression and pathway analyses.

          Results

          Two males with an inherited RAB39B mutation both presented with macrocephaly, intellectual disability (ID), and ASD. Their female sibling with the same mutation presented with ID and a broad autism phenotype. In contrast, their transmitting mother has no neurodevelopmental diagnosis. Our investigation of phase indicated maternal preferential inactivation of the mutated allele, with no such bias observed in the female sibling. We offer the explanation that this bias in X inactivation may explain the absence of a neurocognitive phenotype in the mother. Our cellular knockout model of RAB39B revealed an impact on expression in differentiated neurons for several genes implicated in brain development and function, supported by our pathway enrichment analysis.

          Conclusions

          Penetrance for ASD is high among males but more variable among females with RAB39B mutations. A critical role for this gene in brain development and function is demonstrated.

          Electronic supplementary material

          The online version of this article (10.1186/s13229-017-0175-3) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references13

          • Record: found
          • Abstract: found
          • Article: not found

          Structural variation of chromosomes in autism spectrum disorder.

          Structural variation (copy number variation [CNV] including deletion and duplication, translocation, inversion) of chromosomes has been identified in some individuals with autism spectrum disorder (ASD), but the full etiologic role is unknown. We performed genome-wide assessment for structural abnormalities in 427 unrelated ASD cases via single-nucleotide polymorphism microarrays and karyotyping. With microarrays, we discovered 277 unbalanced CNVs in 44% of ASD families not present in 500 controls (and re-examined in another 1152 controls). Karyotyping detected additional balanced changes. Although most variants were inherited, we found a total of 27 cases with de novo alterations, and in three (11%) of these individuals, two or more new variants were observed. De novo CNVs were found in approximately 7% and approximately 2% of idiopathic families having one child, or two or more ASD siblings, respectively. We also detected 13 loci with recurrent/overlapping CNV in unrelated cases, and at these sites, deletions and duplications affecting the same gene(s) in different individuals and sometimes in asymptomatic carriers were also found. Notwithstanding complexities, our results further implicate the SHANK3-NLGN4-NRXN1 postsynaptic density genes and also identify novel loci at DPP6-DPP10-PCDH9 (synapse complex), ANKRD11, DPYD, PTCHD1, 15q24, among others, for a role in ASD susceptibility. Our most compelling result discovered CNV at 16p11.2 (p = 0.002) (with characteristics of a genomic disorder) at approximately 1% frequency. Some of the ASD regions were also common to mental retardation loci. Structural variants were found in sufficiently high frequency influencing ASD to suggest that cytogenetic and microarray analyses be considered in routine clinical workup.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Gene hunting in autism spectrum disorder: on the path to precision medicine.

            Autism spectrum disorder is typical of the majority of neuropsychiatric syndromes in that it is defined by signs and symptoms, rather than by aetiology. Not surprisingly, the causes of this complex human condition are manifold and include a substantial genetic component. Recent developments in gene-hunting technologies and methods, and the resulting plethora of genetic findings, promise to open new avenues to understanding of disease pathophysiology and to contribute to improved clinical management. Despite remarkable genetic heterogeneity, evidence is emerging for converging pathophysiology in autism spectrum disorder, but how this notion of convergent pathways will translate into therapeutics remains to be established. Leveraging genetic findings through advances in model systems and integrative genomic approaches could lead to the development of new classes of therapies and a personalised approach to treatment.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly.

              Human Mental Retardation (MR) is a common and highly heterogeneous pediatric disorder affecting around 3% of the general population; at least 215 X-linked MR (XLMR) conditions have been described, and mutations have been identified in 83 different genes, encoding proteins with a variety of function, such as chromatin remodeling, synaptic function, and intracellular trafficking. The small GTPases of the RAB family, which play an essential role in intracellular vesicular trafficking, have been shown to be involved in MR. We report here the identification of mutations in the small GTPase RAB39B gene in two male patients. One mutation in family X (D-23) introduced a stop codon seven amino acids after the start codon (c.21C > A; p.Y7X). A second mutation, in the MRX72 family, altered the 5' splice site (c.215+1G > A) and normal splicing. Neither instance produced a protein. Mutations segregate with the disease in the families, and in some family members intellectual disabilities were associated with autism spectrum disorder, epileptic seizures, and macrocephaly. We show that RAB39B, a novel RAB GTPase of unknown function, is a neuronal-specific protein that is localized to the Golgi compartment. Its downregulation leads to an alteration in the number and morphology of neurite growth cones and a significant reduction in presynaptic buttons, suggesting that RAB39B is required for synapse formation and maintenance. Our results demonstrate developmental and functional neuronal alteration as a consequence of downregulation of RAB39B and emphasize the critical role of vesicular trafficking in the development of neurons and human intellectual abilities. Copyright (c) 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                +44 (0)191-282-1384 , marc.woodbury-smith@newcastle.ac.uk
                eric.deneault1@gmail.com
                ryan.yuen@sickkids.ca
                susan.walker@sickkids.ca
                mehdi.zarrei@sickkids.ca
                giovanna.pellecchia@sickkids.ca
                jhowe@sickkids.ca
                ny.hoang@sickkids.ca
                Mohammed.Uddin@mbru.ac.ae
                crm@sickkids.ca
                chrysl@mcmaster.ca
                athomps@mcmaster.ca
                peter.szatmari@sickkids.ca
                stephen.scherer@sickkids.ca
                Journal
                Mol Autism
                Mol Autism
                Molecular Autism
                BioMed Central (London )
                2040-2392
                9 November 2017
                9 November 2017
                2017
                : 8
                : 59
                Affiliations
                [1 ]ISNI 0000 0001 0462 7212, GRID grid.1006.7, Institute of Neuroscience, , Newcastle University, c/o Sir James Spence Institute, ; Queen Victoria Road, Newcastle upon Tyne, NE1 4LP UK
                [2 ]ISNI 0000 0004 0473 9646, GRID grid.42327.30, Program in Genetics and Genome Biology, The Centre for Applied Genomics, , The Hospital for Sick Children, ; Toronto, ON Canada
                [3 ]ISNI 0000 0001 2157 2938, GRID grid.17063.33, McLaughlin Centre, , University of Toronto, ; Toronto, ON Canada
                [4 ]ISNI 0000 0004 0473 9646, GRID grid.42327.30, Autism Research Unit, , The Hospital for Sick Children, ; Toronto, ON Canada
                [5 ]Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
                [6 ]ISNI 0000 0004 1936 8227, GRID grid.25073.33, Department of Psychiatry and Behavioural Neurosciences, , McMaster University, ; Hamilton, ON Canada
                [7 ]ISNI 0000 0004 0473 9646, GRID grid.42327.30, Centre for Addiction and Mental Health, , The Hospital for Sick Children and University of Toronto, ; Toronto, ON Canada
                [8 ]ISNI 0000 0001 2157 2938, GRID grid.17063.33, Department of Molecular Genetics, , University of Toronto, ; Toronto, ON Canada
                Author information
                http://orcid.org/0000-0002-0593-8917
                Article
                175
                10.1186/s13229-017-0175-3
                5679329
                29152164
                fccb5654-f735-4912-8b71-d773901d74cc
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 28 July 2017
                : 16 October 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100008762, Genome Canada;
                Funded by: FundRef http://dx.doi.org/10.13039/501100000092, Ontario Genomics Institute;
                Funded by: FundRef http://dx.doi.org/10.13039/501100000196, Canada Foundation for Innovation;
                Funded by: Ontario Research Fund
                Categories
                Research
                Custom metadata
                © The Author(s) 2017

                Neurosciences
                rab39b,intellectual disability (id),rnaseq,whole genome sequencing (wgs)
                Neurosciences
                rab39b, intellectual disability (id), rnaseq, whole genome sequencing (wgs)

                Comments

                Comment on this article